# Biodesix to Participate in Upcoming Investor Conferences
Canonical URL: https://biopharmsignal.com/news/BDSX/biodesix-to-participate-in-upcoming-investor-conferences-ab591711
Ticker: BDSX
Company: Biodesix
Source: Biodesix
Published: 2026-05-21 10:00 EST
## Summary

Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that members...

## Article Body
Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that members of the Biodesix leadership team will participate in three upcoming investor conferences:

Craig-Hallum 23 rd Annual Institutional Investor Conference 1x1 meetings only Date: Thursday, May 28, 2026 Location: Minneapolis, MN

William Blair 46 th Annual Growth Stock Conference Presentation and 1x1 meetings Presentation Date and Time: Wednesday, June 3, 2026 at 2:00 PM CT Location: Chicago, IL

TD Cowen Annual Tools/Dx Revolution 1x1 meetings only Date: Wednesday, June 24, 2026 Location: Dana Point, CA

The presentation will be webcast live and available for replay under “News & Events” in the Investors section of Biodesix's website at Biodesix.com .

About Biodesix:

Biodesix is a leading diagnostic solutions company, driven to improve clinical care and outcomes for patients. Biodesix Diagnostic Tests , including Nodify Lung ® Nodule Risk Assessment and IQLung ® Cancer Treatment Guidance, support clinical decisions to expedite personalized care and improve outcomes for patients with lung disease. Biodesix Development Services enable the world’s leading biopharmaceutical, life sciences, and research institutions with scientific, technological, and operational capabilities that fuel the development of diagnostic tests, tools, and therapeutics. For more information, visit biodesix.com.

Biodesix Contacts: Media: Natalie St. Denis, Director Corporate Communications natalie.stdenis@biodesix.com (720) 925-9285

Investors: Chris Brinzey, Partner, ICR chris.brinzey@icrhealthcare.com (339) 970-2843
## Recent Company News
- 2026-07-22 10:00 EST — [Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026](https://biopharmsignal.com/news/BDSX/biodesix-to-report-second-quarter-2026-financial-results-on-august-5-2026-cf36c056) — Source: Biodesix
- 2026-05-21 10:00 EST — [Biodesix to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/BDSX/biodesix-to-participate-in-upcoming-investor-conferences-ab591711) — Source: Biodesix
- 2026-05-11 13:17 EST — [Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy](https://biopharmsignal.com/news/BDSX/biodesix-announces-ats-2026-presentations-providing-real-world-clinical-evidence-45441597) — Source: Biodesix
- 2026-05-04 20:01 EST — [Biodesix Announces First Quarter 2026 Results and Highlights](https://biopharmsignal.com/news/BDSX/biodesix-announces-first-quarter-2026-results-and-highlights-c1e0cb2b) — Source: Biodesix
- 2026-04-20 10:00 EST — [Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026](https://biopharmsignal.com/news/BDSX/biodesix-to-report-first-quarter-2026-financial-results-on-may-4-2026-16d481c4) — Source: Biodesix
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:00 EST — NAMS — [NewAmsterdam Pharma to Host Investor Day on August 5, 2026](https://biopharmsignal.com/news/NAMS/newamsterdam-pharma-to-host-investor-day-on-august-5-2026-00cdef02)
- 2026-07-29 11:30 EST — PCSA — [PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREAS](https://biopharmsignal.com/news/PCSA/processa-pharmaceuticals-inc-announces-acquisition-of-vidya-therapeutics-inc-and-589446e2)
- 2026-07-29 11:05 EST — AXGN — [Axogen, Inc. Reports Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/AXGN/axogen-inc-reports-second-quarter-2026-financial-results-4cea3351)
- 2026-07-29 10:54 EST — BDX — [EMS and BD expand access to GLP-1 therapies in Brazil with semaglutide launch](https://biopharmsignal.com/news/BDX/ems-and-bd-expand-access-to-glp-1-therapies-in-brazil-with-semaglutide-launch-ecbaad65)